Term Name: copanlisib
Synonyms: 2-amino-N-{7-methoxy-8-[3-(morpholin-4-yl)propoxy]-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl}pyrimidine-5-carboxamide, BAY 80-6946, BAY-80-6946, BAY80-6946, copanlisib, copanlisibum
Definition: An imidazoquinazoline that is 2,3-dihydroimidazo[1,2-c]quinazoline substituted by (2-aminopyrimidine-5-carbonyl)amino, methoxy, and 3-(morpholin-4-yl)propoxy groups at positions 5, 7 and 8, respectively. It is a intravenous pan-class I PI3K inhibitor used for the treatment of relapsed follicular lymphoma in patients who have received at least 2 prior systemic therapies.
Ontology: ChEBI [CHEBI:173077]  ( EBI )

Relationships
is a type of: aminopyrimidine aromatic ether diether imidazoquinazoline morpholines pyrimidinecarboxamide secondary carboxamide tertiary amino compound
has_role: antineoplastic agent apoptosis inducer EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
inverse has_part: copanlisib dihydrochloride